Low Dose Computed Tomography for Lung Cancer Screening

Overview

About this study

This study will evaluate the impact of a proactive, EHR-supported enrollment strategy that links LDCT-eligible smokers with an evidence-based intervention comprised of a web-based program and integrated text messaging. The goal is to provide actionable findings about how to most effectively and cost efficiently promote abstinence in LDCT clinics.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Scheduled for LDCT screening or have previously undergone the shared decision making session and are returning for their annual LDCT
Current smoking (every day/some days)
At least weekly use of the Internet
Current ownership of cell phone with a text messaging plan
Willing to receive study text messages.
Ability to complete all aspects of the study
Ability to provide signed informed consent

Exclusion Criteria:

Current (in the past 30 days) use of tobacco cessation medication or participation in tobacco cessation treatment.
Those with a condition deemed by the investigators to be exclusionary to the study

More information

Publications

Delivering effective tobacco dependence treatment that is feasible within lung cancer screening (LCS) programs is crucial for realizing the health benefits and cost savings of screening. Large-scale trials and systematic reviews have demonstrated that digital cessation interventions (i.e. web-based and text message) are effective, sustainable over the long-term, scalable, and cost-efficient. Use of digital technologies is commonplace among older adults, making this a feasible approach within LCS programs. Use of cessation treatment has been improved with models that proactively connect smokers to treatment rather than passive referrals. Proactive referral to cessation treatment has been advanced through healthcare systems changes such as modifying the electronic health record to automatically link smokers to treatment. Read More on PubMed

Clinical Trials